| A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment (NCT07293247) | Alliance for Clinical Trials in Oncology | 2026-07-14 |
| Testing the Addition of an Anti-Cancer Drug, Mycophenolate Mofetil, to the Usual Treatment (Radiation Therapy and Temozolomide) for Advanced Brain Cancer (NCT07605364) | Alliance for Clinical Trials in Oncology | 2026-06-10 |
| Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL (NCT07321652) | Alliance for Clinical Trials in Oncology | 2026-04-30 |
| Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial (NCT05379153) | Alliance for Clinical Trials in Oncology | 2026-04-21 |
| Family Communications After Genetic Testing (NCT07143487) | Alliance for Clinical Trials in Oncology | 2026-04-06 |
| Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial (NCT07200830) | Alliance for Clinical Trials in Oncology | 2026-03-31 |
| Distance-Based Exercise to Preserve Function and Prevent Disability (NCT07059884) | Alliance for Clinical Trials in Oncology | 2026-02-11 |
| Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer (NCT07091617) | Alliance for Clinical Trials in Oncology | 2025-12-10 |
| Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial (NCT06931340) | Alliance for Clinical Trials in Oncology | 2025-12-01 |
| ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab (NCT06876714) | Alliance for Clinical Trials in Oncology | 2025-09-17 |
| Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy (NCT07000084) | Alliance for Clinical Trials in Oncology | 2025-07-17 |
| High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer (NCT06992427) | Alliance for Clinical Trials in Oncology | 2025-06-05 |
| Testing the Combination of Two Approved Drugs and One Experimental Drug in Patients With Relapsed or Refractory Multiple Myeloma (NCT06232044) | Alliance for Clinical Trials in Oncology | 2025-04-23 |
| Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer (NCT06661720) | Alliance for Clinical Trials in Oncology | 2025-03-14 |
| Testing Low Dose Tamoxifen for Invasive Breast Cancer, LoTam Trial (NCT06671912) | Alliance for Clinical Trials in Oncology | 2025-02-19 |
| Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial (NCT06632977) | Alliance for Clinical Trials in Oncology | 2025-02-06 |
| Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer (NCT06632327) | Alliance for Clinical Trials in Oncology | 2024-12-11 |
| Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma (NCT05647265) | Alliance for Clinical Trials in Oncology | 2024-11-27 |
| The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer (NCT06115499) | Alliance for Clinical Trials in Oncology | 2024-08-13 |
| Finding an Effective Dose of GM1 to Reduce or Prevent Neuropathy (Numbness or Weakness) Due to Treatment With Paclitaxel (Phase II) (NCT05751668) | Alliance for Clinical Trials in Oncology | 2023-11-02 |
| Testing Continuous Versus Intermittent Treatment With the Study Drug Zanubrutinib for Older Patients With Previously Untreated Mantle Cell Lymphoma (NCT05976763) | Alliance for Clinical Trials in Oncology | 2023-10-20 |
| Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study (NCT05673148) | Alliance for Clinical Trials in Oncology | 2023-10-09 |
| Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer (NCT05710406) | Alliance for Clinical Trials in Oncology | 2023-08-16 |
| Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab (NCT05812807) | Alliance for Clinical Trials in Oncology | 2023-06-14 |
| Comparing Inotuzumab Combined With Low Intensity Chemotherapy Plus Blinatumomab to Usual Chemotherapy Plus Blinatumomab in Older Adults With CD22+ B-cell Acute Lymphoblastic Leukemia (NCT05303792) | Alliance for Clinical Trials in Oncology | 2023-06-09 |
| Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma (NCT05694871) | Alliance for Clinical Trials in Oncology | 2023-06-07 |
| Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors (NCT05247905) | Alliance for Clinical Trials in Oncology | 2023-02-16 |
| Studying the Effect of Denosumab on Preventing Breast Cancer in Women With a BRCA1 Germline Mutation (NCT04711109) | Alliance for Clinical Trials in Oncology | 2023-02-14 |
| mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma (NCT05677490) | Alliance for Clinical Trials in Oncology | 2023-01-31 |
| Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment of Advanced Uveal Melanoma (NCT05677373) | Alliance for Clinical Trials in Oncology | 2023-01-13 |
| Testing the Addition of an Anti-Cancer Drug, Irinotecan, to the Standard Chemotherapy Treatment (FOLFOX) After Long-Course Radiation Therapy for Advanced-Stage Rectal Cancers to Improve the Rate of Complete Response and Long-Term Rates of Organ Preservation (NCT05610163) | Alliance for Clinical Trials in Oncology | 2022-12-08 |
| Testing Interruption of Hormonal Medications in Patients Responding Exceptionally to Therapy for Metastatic Prostate Cancer, (A-DREAM) (NCT05241860) | Alliance for Clinical Trials in Oncology | 2022-11-21 |
| Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection (NCT05334069) | Alliance for Clinical Trials in Oncology | 2022-08-18 |
| Testing the Application of Mepitel Film During Radiation Therapy to Reduce Radiation Related Redness and Peeling in Breast Cancer Patients Following Mastectomy (NCT04989504) | Alliance for Clinical Trials in Oncology | 2022-07-26 |
| Trying to Find the Correct Length of Treatment With Immune Checkpoint Therapy (NCT04637594) | Alliance for Clinical Trials in Oncology | 2022-05-27 |
| Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program (NCT05008848) | Alliance for Clinical Trials in Oncology | 2022-04-01 |
| Olanzapine Versus Megestrol Acetate for the Treatment of Loss of Appetite Among Advanced Cancer Patients (NCT04939090) | Alliance for Clinical Trials in Oncology | 2022-01-03 |
| Testing the Effects of Oxybutynin for the Treatment of Hot Flashes in Men Receiving Hormone Therapy for Prostate Cancer (NCT04600336) | Alliance for Clinical Trials in Oncology | 2021-10-28 |
| A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy (NCT04455750) | Alliance for Clinical Trials in Oncology | 2021-10-14 |
| Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma (NCT04803201) | Alliance for Clinical Trials in Oncology | 2021-10-08 |
| T-DM1 and Tucatinib Compared With T-DM1 Alone in Preventing Relapses in People With High Risk HER2-Positive Breast Cancer, the CompassHER2 RD Trial (NCT04457596) | Alliance for Clinical Trials in Oncology | 2021-03-02 |
| Improving Patient-Centered Communication in Breast Cancer Through Patient and Provider Interventions (NCT04549571) | Alliance for Clinical Trials in Oncology | 2021-02-16 |
| Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer (NCT04533451) | Alliance for Clinical Trials in Oncology | 2020-11-16 |
| Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer (NCT04137107) | Alliance for Clinical Trials in Oncology | 2020-06-17 |
| Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects (NCT04242095) | Alliance for Clinical Trials in Oncology | 2020-03-12 |
| Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease (NCT04114981) | Alliance for Clinical Trials in Oncology | 2019-11-19 |
| Vitamin D3 With Chemotherapy and Bevacizumab in Treating Patients With Advanced or Metastatic Colorectal Cancer (NCT04094688) | Alliance for Clinical Trials in Oncology | 2019-10-29 |
| Genetic Testing in Guiding Treatment for Patients With Brain Metastases (NCT03994796) | Alliance for Clinical Trials in Oncology | 2019-10-17 |
| Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection (NCT03927027) | Alliance for Clinical Trials in Oncology | 2019-07-29 |
| Use of a Pre-Surgical Toolkit in Improving Surgical Care and Outcomes in Older Participants With Cancer (NCT03857620) | Alliance for Clinical Trials in Oncology | 2019-07-24 |
| Avelumab With or Without Cetuximab in Treating Patients With Advanced Skin Squamous Cell Cancer (NCT03944941) | Alliance for Clinical Trials in Oncology | 2019-06-17 |
| Increasing Patients' Engagement in Breast Cancer Surgery Decision-Making (NCT03766009) | Alliance for Clinical Trials in Oncology | 2019-06-05 |
| Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer (NCT03839940) | Alliance for Clinical Trials in Oncology | 2019-06-03 |
| Assessment of Financial Difficulty in Participants with Chronic Lymphocytic Leukemia and Multiple Myeloma (NCT03870633) | Alliance for Clinical Trials in Oncology | 2019-05-14 |
| Evaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502 (NCT03609021) | Alliance for Clinical Trials in Oncology | 2019-02-26 |
| Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations (NCT03609216) | Alliance for Clinical Trials in Oncology | 2018-12-10 |
| Olanzapine With or Without Fosaprepitant Dimeglumine in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients Receiving Highly Emetogenic Chemotherapy (NCT03578081) | Alliance for Clinical Trials in Oncology | 2018-11-20 |
| Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2 Negative Metastatic Breast Cancer (NCT03633331) | Alliance for Clinical Trials in Oncology | 2018-08-15 |
| Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer (NCT03414970) | Alliance for Clinical Trials in Oncology | 2018-03-12 |
| Pulmonary Rehabilitation Before Lung Cancer Resection (NCT02887521) | Alliance for Clinical Trials in Oncology | 2018-02-28 |
| Vemurafenib and Cobimetinib in Treating Patients With BRAF V600E Mutation Positive Craniopharyngioma (NCT03224767) | Alliance for Clinical Trials in Oncology | 2018-01-05 |
| Decision Aids in Improving Knowledge in Patients With Newly Diagnosed Prostate Cancer (NCT03103321) | Alliance for Clinical Trials in Oncology | 2017-10-02 |
| Management of Tobacco Treatment Intervention in Reducing Surgical Complications in Patients With Newly Diagnosed Lung Cancer Who Smoke Cigarettes (NCT02856581) | Alliance for Clinical Trials in Oncology | 2017-09-29 |
| Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia (NCT03150693) | Alliance for Clinical Trials in Oncology | 2017-09-20 |